In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose

被引：24

作者：

Chagla, Zain ^{[1
]}

机构：

[1] McMaster Univ, Hamilton, ON, Canada

来源：

ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 03期

关键词：

D O I：

10.7326/ACPJ202103160-028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：JC28 / JC28

页数：1

共 50 条

[21] Humoral response to BNT162b2-COVID-19 or CoronaVac vaccine against COVID-19 in people with multiple sclerosis patients treated with high efficacy therapies
Galleguillos, L.
Alonso, R.
Kagi, M.
Hernandez, M.
Diaz, V.
Pallauta, K.
Jerez, M. E.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 792 - 792
[22] Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic
Namgung, Song Hee
Jung, Jiwon
Kim, Sun Kyung
Kim, Eun Ok
Jo, Kyung-Wook
Shim, Tae Sun
Kim, Sung-Han
JOURNAL OF INFECTION, 2023, 87 (04) : 344 - 345
[23] In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d
Bikdeli, Behnood
Garcia, David A.
ANNALS OF INTERNAL MEDICINE, 2022, 175 (02) : JC17 - JC17
[24] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
Procter, Brian C.
Ross, Casey
Pickard, Vanessa
Smith, Erica
Hanson, Cortney
McCullough, Peter A.
REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (04) : 611 - 614
[25] Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
Leung, Daniel
Cohen, Carolyn A.
Mu, Xiaofeng
Rosa Duque, Jaime S.
Cheng, Samuel M. S.
Wang, Xiwei
Wang, Manni
Zhang, Wenyue
Zhang, Yanmei
Tam, Issan Y. S.
Lam, Jennifer H. Y.
Chan, Sau Man
Chaothai, Sara
Kwan, Kelvin K. H.
Chan, Karl C. K.
Li, John K. C.
Luk, Leo L. H.
Tsang, Leo C. H.
Chu, Nym Coco
Wong, Wilfred H. S.
Mori, Masashi
Leung, Wing Hang
Valkenburg, Sophie
Peiris, Malik
Tu, Wenwei
Lau, Yu Lung
FRONTIERS IN IMMUNOLOGY, 2023, 14
[26] Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Torres, Montserrat
Casado, Guiomar
Vigon, Lorena
Rodriguez-Mora, Sara
Mateos, Elena
Ramos-Martin, Fernando
Lopez-Wolf, Daniel
Sanz-Moreno, Jose
Ryan-Murua, Pablo
Luisa Taboada-Martinez, Maria
Rosa Lopez-Huertas, Maria
Cervero, Miguel
Coiras, Mayte
BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
[27] COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
Cédric Annweiler
Mélinda Beaudenon
Jennifer Gautier
Romain Simon
Vincent Dubée
Justine Gonsard
Elsa Parot-Schinkel
Trials, 21
[28] COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
Annweiler, Cedric
Beaudenon, Melinda
Gautier, Jennifer
Simon, Romain
Dubee, Vincent
Gonsard, Justine
Parot-Schinkel, Elsa
TRIALS, 2020, 21 (01)
[29] Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial
Spyropoulos, Alex C.
Goldin, Mark
Giannis, Dimitrios
Diab, Wassim
Wang, Janice
Khanijo, Sameer
Mignatti, Andrea
Gianos, Eugenia
Cohen, Marc
Sharifova, Gulru
Lund, Jeet M.
Tafur, Alfonso
Lewis, Paul A.
Cohoon, Kevin P.
Rahman, Husneara
Sison, Cristina P.
Lesser, Martin L.
Ochani, Kanta
Agrawal, Nirav
Hsia, Judith
Anderson, Victoria E.
Bonaca, Marc
Halperin, Jonathan L.
Weitz, Jeffrey, I
JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1612 - 1620
[30] T cell response in immunosuppressed redo-liver transplant recipients after COVID-19 infection and after first dose of vaccine against SARS-CoV-2
Lovatt, J.
Lam, S.
Carter, C.
Nadat, F.
Moore, J.
Chimakurthi, C. R.
Fiore, B.
Attia, M.
Page, E.
Prasad, R.
Savic, S.
TRANSPLANTATION, 2021, 105 (08) : 156 - 156

← 1 2 3 4 5 →